Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Puoti and Alessandro Cozzi-Lepri.
Connection Strength
0.197
-
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
Score: 0.058
-
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort. HIV Clin Trials. 2018 04; 19(2):52-60.
Score: 0.047
-
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients. PLoS One. 2018; 13(1):e0190302.
Score: 0.047
-
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. PLoS One. 2017; 12(5):e0177402.
Score: 0.045